Analysis

FCA Chases 'Shrewder' Kickbacks As 50-Year Hunt Intensifies

By Jeff Overley ( May 10, 2023, 7:20 PM EDT) -- When sophisticated drug and device companies have confronted deadly diseases and daunting approval standards, they've hired the brightest scientific and legal minds or bribed prescribers with cash, liquor, steaks, vacations and lap dances. The latter approach undergirds a landmark law that has been fueling litigation, wrecking physician careers, sullying corporate reputations and generating jaw-dropping headlines for 50 years and that enters its next half-century chasing a new generation of camouflaged kickbacks. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login